Quest Diagnostics Raises 2026 EPS, Revenue Guidance
Summary
Quest Diagnostics (DGX) said, for full year 2026, the company now expects adjusted diluted EPS in a range of $10.63 $10.83, revised from prior guidance range of...
Description
Quest Diagnostics (DGX) said, for full year 2026, the company now expects adjusted diluted EPS in a range of $10.63 $10.83, revised from prior guidance range of...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source